Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In preclinical animal studies on obese mice and rats, retatrutide led to body-weight reductions of 2030 % within 12 weeks, significantly stronger than semaglutide comparison groups
In 2025, researchers are more vigilant than ever about sourcing their compounds from reputable suppliers
Wegovy, like other GLP-1 medications, may increase stomach paralysis risk
Multifaceted roles of GLP-1 and its analogs: A review on pharmacological mechanisms and therapeutic applications
Sources MHRA Drug Safety Update Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), 5 February 2026 BMJ Semaglutide and NAION, February 2026 Community Pharmacy England MHRA Drug Safety Update: Semaglutide and NAION, 5 February 2026 NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
US$ 23.74
US$ 25.47
US$ 21.00
US$ 29.35
